CAH
Cardinal Health, Inc. NYSE$195.24
Mkt Cap $47.2B
52w Low $136.71
60.4% of range
52w High $233.60
50d MA $214.58
200d MA $188.96
P/E (TTM)
30.1x
EV/EBITDA
14.8x
P/B
—
Debt/Equity
-3.4x
ROE
-56.5%
P/FCF
21.9x
RSI (14)
—
ATR (14)
—
Beta
0.65
50d MA
$214.58
200d MA
$188.96
Avg Volume
1.7M
About
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 2.79 | 3.17 | +13.6% | 192.88 | +1.8% | +1.2% | — | — | — | — | — | — |
| Feb 5, 2026 | TNS | 2.34 | 2.63 | +12.4% | 227.18 | -0.4% | -0.4% | -0.6% | -3.0% | -1.3% | -5.3% | -2.2% | — |
| Oct 30, 2025 | TNS | 2.18 | 2.55 | +17.0% | 189.84 | +1.2% | +0.5% | +0.2% | +2.9% | +3.7% | +4.3% | +9.6% | — |
| Aug 12, 2025 | TNS | 2.04 | 2.08 | +2.0% | 146.30 | +0.9% | +1.2% | +2.7% | +2.3% | +2.3% | +1.9% | +4.2% | — |
| May 1, 2025 | TNS | 2.17 | 2.35 | +8.3% | 145.53 | +1.2% | +2.7% | +4.4% | +4.2% | +5.5% | +1.2% | +6.7% | — |
| Jan 30, 2025 | TNS | 1.74 | 1.93 | +10.9% | 128.26 | -1.1% | -3.6% | -2.3% | -2.4% | -0.6% | -0.9% | +0.7% | — |
| Nov 1, 2024 | TNS | 1.62 | 1.88 | +16.0% | 116.13 | +0.8% | -3.6% | -2.5% | -0.5% | +1.8% | +3.8% | +5.5% | — |
| Aug 14, 2024 | TNS | 1.73 | 1.84 | +6.4% | 106.36 | -1.3% | +1.5% | +3.3% | +3.2% | +2.4% | +3.1% | +6.4% | — |
| May 2, 2024 | TNS | 1.95 | 2.08 | +6.7% | 102.98 | -1.3% | -4.0% | -4.3% | -3.2% | -5.4% | -4.8% | -3.4% | — |
| Feb 1, 2024 | TNS | 1.60 | 1.82 | +13.8% | 105.10 | +0.7% | -1.6% | -1.4% | -1.0% | +0.5% | -2.3% | +7.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Citigroup | Maintains | Buy → Buy | — | $192.88 | $196.37 | +1.8% | +1.2% | — | — | — | — |
| May 1 | TD Cowen | Maintains | Buy → Buy | — | $192.88 | $196.37 | +1.8% | +1.2% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $192.88 | $196.37 | +1.8% | +1.2% | — | — | — | — |
| Apr 28 | William Blair | Initiates | Outperform | — | $202.34 | $204.73 | +1.2% | +1.6% | +0.2% | -4.7% | -3.5% | — |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $212.77 | $213.19 | +0.2% | +1.1% | +1.4% | +1.3% | +0.7% | +1.0% |
| Feb 24 | Barclays | Maintains | Overweight → Overweight | — | $224.82 | $224.52 | -0.1% | +0.5% | +0.6% | +1.0% | +2.0% | +2.3% |
| Feb 10 | JP Morgan | Maintains | Neutral → Neutral | — | $225.76 | $226.00 | +0.1% | -2.4% | -0.7% | -4.7% | -2.2% | -0.1% |
| Feb 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $225.76 | $226.00 | +0.1% | -2.4% | -0.7% | -4.7% | -2.2% | -0.1% |
| Feb 6 | Mizuho | Maintains | Outperform → Outperform | — | $227.18 | $226.21 | -0.4% | -0.4% | -0.6% | -3.0% | -1.3% | -5.3% |
| Jan 29 | Morgan Stanley | Maintains | Overweight → Overweight | — | $210.39 | $212.46 | +1.0% | +0.4% | +2.1% | +4.1% | +3.6% | -1.7% |
Recent Filings
8-K · 7.01
! Medium
Cardinal Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Cardinal Health executives will present Q3 2026 earnings results and fiscal year guidance via webcast on April 30, 2026, providing investors an opportunity to assess the company's operational performance and forward-looking strategy.
Apr 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Vafa Jamali's appointment as director signals potential strategic shifts in governance and decision-making, warranting investor attention to board composition changes affecting corporate direction and oversight quality.
Apr 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Cardinal Health (CAH) appointed a new CFO, signaling potential strategic shifts in financial management and operational efficiency that could impact investor confidence in company direction and capital allocation decisions.
Mar 31
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Cardinal Health's appointment of Patricia A. Hemingway Hall as Board Chair signals leadership stability and potential strategic direction, likely reassuring investors about governance quality and future decision-making at the healthcare distributor.
Mar 23
8-K · 5.02
!!! Very High
Cardinal Health, Inc. -- 8-K 5.02: Executive Change
Cardinal Health's Chief Accounting Officer Mary Scherer is departing, triggering a leadership transition that investors should monitor for potential accounting function disruptions during the successor search.
Mar 5
8-K
Albertsons Companies, Inc. -- 8-K Filing
I need more complete information to provide analysis. The summary provided appears truncated and doesn't clarify what action Albertsons took (appointment, departure, partnership, etc.) or how it impacts investors—please provide the full summary.
Feb 27
8-K · 7.01
! Medium
Cardinal Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Cardinal Health executives will discuss Q2 2026 earnings results and updated fiscal guidance during a February 5 webcast, providing investors with near-term performance insights and forward-looking outlook.
Feb 5
Data updated apr 24, 2026 11:41pm
· Source: massive.com